Evidence map›Paper›PMID 28179656›Full record

ReviewNature2017

Inflammation, metaflammation and immunometabolic disorders.

Gökhan S Hotamisligil

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,430 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,430citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,430 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

1,370 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gökhan S HotamisligilDepartment of Genetics and Complex Diseases and Sabri Ülker Center, Harvard T.H. Chan School of Public Health, Broad Institute of Harvard and MIT, Boston, Massachusetts 02115, USA.

Funding

TNF RECEPTOR FUNCTION IN INSULIN RESISTANCE AND OBESITYR01DK052539 · NIDDK · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI HOTAMISLIGIL, GOKHAN S · 1998 to 2017
$6.8M
The role of fatty acid binding protein aP2 in the pathogenesis and treatment of asthmaR01AI116901 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HOTAMISLIGIL, GOKHAN S · 2015 to 2018
$1.6M
The role of immunometabolic pathways in atherosclerosisR01HL125753 · NHLBI · HARVARD SCHOOL OF PUBLIC HEALTH · PI HOTAMISLIGIL, GOKHAN S · 2015 to 2018
$1.6M
NHLBI NIH HHS R01 HL125753NIAID NIH HHS R01 AI116901NIDDK NIH HHS R01 DK052539
6 · The paper itself

Abstract

Proper regulation and management of energy, substrate diversity and quantity, as well as macromolecular synthesis and breakdown processes, are fundamental to cellular and organismal survival and are paramount to health. Cellular and multicellular organization are defended by the immune response, a robust and critical system through which self is distinguished from non-self, pathogenic signals are recognized and eliminated, and tissue homeostasis is safeguarded. Many layers of evolutionarily conserved interactions occur between immune response and metabolism. Proper maintenance of this delicate balance is crucial for health and has important implications for many pathological states such as obesity, diabetes, and other chronic non-communicable diseases.

Indexed as

Adaptive ImmunityAnimalsClinical Trials as TopicCytokinesEvolution, MolecularGenome-Wide Association StudyHormonesHumansInflammationInvertebratesMetabolic DiseasesObesityOrganellesSignal TransductionCytokinesHormones

Identifiers

PMID28179656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.